Andrew J. Pollard
Elite in Typhoid Fever

Andrew J. Pollard

Oxford, ENG, GB 
Elite in Typhoid Fever
Oxford, ENG, GB 
OverviewLocationsClinical Research

Overview

Andrew Pollard practices in Oxford, United Kingdom. Sir Pollard is rated as an Elite expert by MediFind in the treatment of Typhoid Fever. His top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Tetanus, Parainfluenza, and Adenoidectomy.

His clinical research consists of co-authoring 619 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 106 articles and participated in 2 clinical trials in the study of Typhoid Fever.

Gender
Male

Locations

Oxford, ENG, United Kingdom
Other Locations
Middlesex, ENG TW110LW, United Kingdom
Hampton Road, Teddington, ENG TW110LW, United Kingdom
Liverpool, ENG, United Kingdom
Stevenage, ENG, United Kingdom
London, ENG, United Kingdom
Lower Maudlin St, Bristol, ENG BS12LY, United Kingdom
Truro, ENG, United Kingdom
Brighton, ENG, United Kingdom
Newcastle Upon Tyne, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19
A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Biological
Study Drugs: ChAdOx1 COVID-19 Vaccine, MenACWY COVID-19 Vaccine, Paracetamol
Study Phase: Phase 2/Phase 3
A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis
A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis
Enrollment Status: Completed
Publish Date: March 04, 2024
Intervention Type: Drug
Study Drug: Immunoglobulins
Study Phase: Phase 3
Sourcing Human Blood Products to Support the Development of New Vaccines Against Infectious Diseases
Sourcing Human Blood Products to Support the Development of New Vaccines Against Infectious Diseases
Enrollment Status: Completed
Publish Date: April 04, 2023
REspiratory Syncytial Virus Consortium in EUrope (RESCEU):Presumed Risk Factors and Biomarkers for RSV-related Severe Disease and Related Sequelae
REspiratory Syncytial Virus Consortium in EUrope (RESCEU):Presumed Risk Factors and Biomarkers for RSV-related Severe Disease and Related Sequelae
Enrollment Status: Active_not_recruiting
Publish Date: November 22, 2022
Intervention Type: Diagnostic test
FluPRINT Study OVG 2018/04: Characterisation of the Immune & Transcriptional Responses to Live Attenuated Influenza Vaccine (LAIV) in Healthy 4-6-year-old Children
FluPRINT Study OVG 2018/04: Characterisation of the Immune & Transcriptional Responses to Live Attenuated Influenza Vaccine (LAIV) in Healthy 4-6-year-old Children
Enrollment Status: Completed
Publish Date: June 30, 2022
Intervention Type: Other
Study Phase: Not Applicable
Investigating the Mechanisms and Determinants of Systemic and Mucosal Immunity to Salmonella Typhi and Salmonella Paratyphi A in naïve and Previously Exposed Individuals - A Challenge and Rechallenge Study
Investigating the Mechanisms and Determinants of Systemic and Mucosal Immunity to Salmonella Typhi and Salmonella Paratyphi A in naïve and Previously Exposed Individuals - A Challenge and Rechallenge Study
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Biological
Study Phase: Not Applicable
Exploring the Bottleneck Hypothesis of the Pathogenesis of Bacteraemia in an Ambulatory Outpatient Human Experimental Infection of Salmonella Typhi
Exploring the Bottleneck Hypothesis of the Pathogenesis of Bacteraemia in an Ambulatory Outpatient Human Experimental Infection of Salmonella Typhi
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Biological
Study Phase: Not Applicable
A Randomised Controlled Trial Comparing Two-Dose Priming With the 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks to 6 and 14 Weeks in Nepali Children
A Randomised Controlled Trial Comparing Two-Dose Priming With the 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks to 6 and 14 Weeks in Nepali Children
Enrollment Status: Completed
Publish Date: January 11, 2018
Intervention Type: Biological
Study Phase: Phase 4
View 7 Less Clinical Trials

617 Total Publications

Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.
Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.
Journal: JAMA network open
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sir Pollard's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 12 Advanced Conditions
View All 52 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile